GAIN THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.52 USD | -5.97% |
|
-15.02% | -23.74% |
| 04-24 | Gain Therapeutics, Inc. Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287 | CI |
| 04-08 | Gain Therapeutics Names Gene Mack as CFO | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GAIN THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -7.09% | -15.02% | -23.74% | -51.74% | - | 48.38M | - | - | - |
- Stock Market
- Equities
- GANX Stock
- Charts Gain Therapeutics, Inc.
- Relative Strength Chart